Profil
Rami Skaliter is currently the Chief Executive Officer at Cell Cure Neurosciences Ltd., an External Director at Tikcro Technologies Ltd., and was previously the Chief Operating Officer at Quark Pharmaceuticals, Inc. He received an undergraduate degree from Ben-Gurion University of the Negev and graduate and doctorate degrees from Weizmann Institute of Science.
Postes actifs de Rami Skaliter
| Sociétés | Poste | Début |
|---|---|---|
| TIKCRO TECHNOLOGIES LTD. | Directeur/Membre du Conseil | 01/01/2016 |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Develops cell therapies for neural degenerative diseases | Directeur Général | 01/06/2017 |
Anciens postes connus de Rami Skaliter
| Sociétés | Poste | Fin |
|---|---|---|
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops novel RNAi-based therapeutics | Directeur des opérations | - |
Formation de Rami Skaliter
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Tikcro Technologies Ltd.
Tikcro Technologies Ltd. BiotechnologyHealth Technology Develops and distributes biotechnology technologies | Health Technology |
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops novel RNAi-based therapeutics | Health Technology |
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weizmann Institute of Science
Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Develops cell therapies for neural degenerative diseases | Health Technology |
















